- $877.15m
- $371.52m
- $67.48m
U.S. STOCKS ON THE MOVE-McKesson, Dick's Sporting Goods, Madison Air Solutions
Kura Oncology leaps after CEO buys more stock
Kura jumps on narrower-than-expected quarterly loss
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Kura Oncology, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kura Oncology Q2 product revenue rises 57% on KOMZIFTI uptake
Brief: Kura Oncology Q2 Operating Expenses USD 93.884 Million
Kura Oncology, Inc. expected to post a loss of 88 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Kura Oncology up as leukemia drug shows strong survival in early- to mid-stage trial
Refile: Kura Oncology records revenue in Q1, but loss widens on higher costs
Kura Oncology rises as kidney cancer combo shows early promise
Brief: Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks
U.S. STOCKS ON THE MOVE-American Eagle Outfitters, gold miners, EPAM
U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
Kura falls after downbeat fourth-quarter results